“An entire industry is about to be wiped out”

According to Jennie Ekbeck, CEO of Umeå Biotech Incubators, Sweden risks not having any small diagnostic companies left in five years.

Genterapier och vaccin dryftas på branschmötet

Stockholm aims at becoming one of the world’s top life science regions

Regional Chair for Finance, Irene Svenonius (M), believes that Stockholm can realise the goal of becoming one of the world’s top 5 regions in life science by 20...

A growing industry in Denmark: “One new life science company a week”

The life science sector in eastern Denmark continues to grow in the number of employees, as well as the number of companies. An emerging problem is the shortage...

Norway finds its path in life science

The life science sector in Norway is on the rise.

Ny modell ger ytterligare stöd för munskydd: ”Ger ett utmärkt skydd”

Forskare vid bland annat Chalmers har tagit fram en modell för att mäta hur virus färdas genom luften – och hur effektivt munskydd är för att hindra smittspridn...

Founder of Bioarctic, Lars Lannfelt, is honoured: “I want to create something for the future”

It´s like a scientist’s dream: to be the world’s first with a drug that genuinely affects one of our major diseases. Lars Lannfelt and his company Bioarctic hav...

The first vaccine derived from cowpox

The British rural doctor could not forget the words of the peasant girl. Could that really be true? A couple of decades later, on 14 May 1796, he performed the ...

MVA:s CEO: “Our investments should improve people´s everyday lives”

Involuntary infertility and diabetes are two of the areas on the agenda of the Medicon Valley Alliance.

They’re all doing it – buying drug research

It is not easy to navigate the complex infrastructure for drug development in Sweden, where various contract players exist alongside the pharmaceutical companies.

Astra Zeneca’s Sweden CEO: “We have great faith in our portfolio”

It all started with a summer job as an operator at Astra’s chemical factory in Snäckviken, just outside Södertälje. More than three decades and countless differ...

Academia - a strong player on the lab market

While the industry was short of money during the financial crisis, government incentives were in full swing in Sweden during 2009. - Our sales to academia incre...

Sweden and Denmark – this is how they choose their strategies

Scandinavia’s two major powers in pharmaceutical research have developed strategies for growth in life science, and both countries aim to become world leaders.

Kosmitta gav vaccin mot smittkoppor

Bondflickans ord ville inte lämna den brittiske landsortsläkarens huvud. Kunde det verkligen stämma? Ett par decennier senare, den 14 maj 1796, genomförde han v...

Epilepsigener pekar mot ny behandling

I den största internationella studien i sitt slag har 11 nya gener kopplade till epilepsi upptäckts.

Jämställdhet brister för kvinnliga kemister

Andelen kvinnliga professorer vid kemiinstitutioner har ökat från knappt fem procent till cirka 9 procent mellan 2005 och 2015, vid brittiska universitet.

Crafoord Prize to an American and two Japanese

Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.

Orsakssamband mellan överflödigt kroppsfett och hjärtkärlsjukdom

Det är skillnad på att riskfaktorer faktiskt orsakar en sjukdom eller bara förekommer i samband med dem. Genom så kallad Mendelsk randomisering visar KI-forskar...

Stort intresse för migränstudie

Intresseanmälningarna att delta i klinisk studie har överträffat förväntningarna.

Bought a tablet factory – and built his own empire

In 1995, Thomas Eldered was CEO of one of Pharmacia’s factories in the Stockholm area when the Swedish pharmaceutical giant, after a takeover, decided to move i...

Swedish life science in political focus

It feels like 2017 will be a good year for Swedish life science, says Anders Blanck, CEO at LIF.

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.

Ny vd på Lundbeck

Det danska läkemedelsföretaget knycker chef från Novo Nordisk.

Anders Persson får brittiskt medicinpris

Anders Persson prisas med brittiskt forskningspris.